Investment Daily Note
类型：投资策略 机构：新鸿基投资服务有限公司 研究员：新鸿基投资研究所 日期：2015-06-12
http://www.zdcj.net 点击收藏此报告
3SBio (1530.HK), a leading biotechnology company in Mainland China, commences trading today after a 201-times oversubscription.
Mainland China’s Ministry of Finance has recently approved another RMB 1 trillion local government debt swap, which will be positive for the Chinese banking sector.
相关报告：
热点推荐：
